RTW INVESTMENTS, LP

Position in IMVT — Immunovant, Inc.

CIK 1493215 NEW YORK, NY

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$122,442,521

+$43,504,752 QoQ

Shares Held

3,177,849

0.0% QoQ

Ownership

1.54%

of shares outstanding

% of Portfolio

1.05%

of 13F equity value

Holder Rank

#12

of 226 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RTW INVESTMENTS, LP holds $9,530,420,260 across 63 Biotechnology names. IMVT ranks #24 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	1,993,687	$1,070,510,234
2	ARGX	Argenx SE	709,446	$658,202,715
3	PTCT	Ptc Therapeutics, Inc.	7,746,415	$631,875,071
4	PTGX	Protagonist Therapeutics, Inc	5,061,175	$620,398,831
5	CGON	CG Oncology, Inc.	8,514,590	$604,961,619
6	INSM	INSMED Inc	4,842,880	$516,347,865
7	TNGX	Tango Therapeutics, Inc.	13,900,620	$434,533,381
8	SYRE	Spyre Therapeutics, Inc.	4,251,996	$377,492,204

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$122,442,521	3,177,849	0.0%	Shares	Sole	2026-08-14
2026-03-31	$78,937,769	3,177,849	-0.0%	Shares	Sole	2026-05-15
2025-12-31	$80,780,947	3,177,850	+498.9%	Shares	Sole	2026-02-17
2024-12-31	$13,143,308	530,614	-91.7%	Shares	Sole	2025-02-14
2021-03-31	$101,962,157	6,356,743	-16.3%	Shares	Sole	2021-05-14
2020-12-31	$350,686,166	7,592,253	+1.1%	Shares	Sole	2021-02-16
2020-09-30	$264,291,398	7,510,412	+31.4%	Shares	Sole	2020-11-16
2020-06-30	$139,213,381	5,717,182	+29.2%	Shares	Sole	2020-08-14
2020-03-31	$68,892,339	4,426,106	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.